PIRB WT MLL-AF9 engrafted mice also demonstrated markedly reduced survival compared to PIRB deficient MLL-AF9 engrafted mice, demonstrating the impact to pathogenesis of increased AML stemness. This evidence concerns the gene KMT2A and acute myeloid leukemia.